Interventions to decrease HIV infectiousness in Uganda

降低乌干达艾滋病毒感染率的干预措施

• 批准号: 8044884
• 负责人: CONNIE L CELUM
• 金额: $ 390万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-30 至 2015-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8044884
• 关键词: AIDS prevention; Africa; Area; Attitude; Behavioral; Caring; Clinical; Clinical Services; Communities; Costs and Benefits; Counseling; Couples; Diagnostic; Disclosure; Epidemic; Epidemiology; Family; Frequencies; Funding; Guidelines; HIV; Home environment; Household; Human immunodeficiency virus test; Incidence; Infection; Intervention; Knowledge; Learning; Malaria; Measures; Methods; Modeling; Persons; Plasma; Population; Prevalence; Prevention; Prevention Guidelines; Prevention program; Preventive; Preventive Intervention; Probability Samples; Research; Risk; Risk Behaviors; Risk Reduction; Services; Sex Behavior; Stigmata; Surveys; Target Populations; Testing; Triage; Uganda; United States National Institutes of Health; Viral Load result; Visit; antiretroviral therapy; base; behavior change; condoms; cost; design; evidence base; follow-up; global health; men; novel; point of care; programs; public health relevance; response; scale up; social stigma; success; transmission process; uptake

DESCRIPTION (provided by applicant): This application, Interventions to decrease HIV infectiousness in Uganda, responds to the NIH Director's Opportunity for Research (RC-4) within the Global Health theme. Novel, cost-effective strategies are needed to efficiently deliver proven HIV prevention and treatment services in Africa to have a substantial impact on population HIV incidence. We posit that HIV transmission in a community can be reduced through targeted, population-level delivery of HIV prevention and care services to HIV+ persons, through increasing knowledge of HIV+ status with associated behavior change and reducing HIV infectiousness through initiation of antiretroviral therapy (ART), and prevention and treatment of co-infections such as malaria. Home-based HIV counseling and testing programs, HBCT, have achieved large scale knowledge of HIV serostatus. We will build on the HBCT platform ("HBCT-plus") with targeted diagnostic, preventive, and treatment services for HIV+ persons and behavioral counseling to reduce HIV infectiousness, which will augment our Methods of Prevention Program Project (MP-3) research in Uganda. We will implement HBCT-plus in 5000 households in a high HIV prevalence area in Uganda with point-of-care (POC) CD4 testing to triage HIV+ persons to ART following Uganda guidelines and prevention and treatment of co-infections for all HIV+ persons. We will deliver prevention-for-positives risk-reduction counseling and discordant couples counseling to reduce risk behaviors. We will conduct quarterly follow-up visits for one year to optimize uptake of clinical interventions and to assess risk behaviors and stigma. Measures of success of HBCT-plus will be impact on: 1) community viral load (average HIV plasma viral load in the community over 12 months), a marker of population-level HIV infectiousness, and 2) HIV transmission potential, a composite measure of viral load and sexual behavior among HIV+ persons with HIV- or unknown serostatus partners, who have the greatest impact on HIV spread. Specific Aims: 1) Demonstrate feasibility of HBCT-plus, with HIV testing, POC CD4 testing to triage HIV+ persons to care, and prevention-for-positives and discordant couples counseling, delivered to 5000 households in Uganda in one year, based on >90% uptake of testing and >80% linkage to care among HIV+ persons. 2) Measure the impact of HBCT-plus on HIV transmission risk in the community through assessment of community viral load and HIV transmission potential before and after HBCT- plus. 3) Measure disclosure to partners and family, HIV testing of partners, condom use, sexual frequency, and number of partners before and after positive prevention counseling for newly-identified HIV+ persons through HBCT-plus. 4) Evaluate the effect of HBCT-plus on community risk behaviors, attitudes about HIV testing, and stigma through a probability sample survey in the community. 5) Determine the incremental costs of HBCT and additional components in HBCT-plus for facilitated HIV care and counseling, and estimate the cost-benefit of community viral load reduction. PUBLIC HEALTH RELEVANCE: HBCT-plus is a home-based HIV testing program in Uganda to increase knowledge of HIV+ status with associated behavior change, and reduce HIV infectiousness through effective linkages to antiretroviral therapy and treatment of co-infections, and assessed by reduction in community viral load and transmission potential.

描述（由申请人提供）：该申请，干预措施，以减少乌干达艾滋病毒的传染性，响应NIH主任的研究机会（RC-4）在全球卫生主题。需要新的具有成本效益的战略，以便在非洲有效地提供经证实的艾滋病毒预防和治疗服务，从而对人口艾滋病毒发病率产生重大影响。我们假设，通过有针对性地在人群层面上向HIV+人群提供HIV预防和护理服务，通过增加对HIV+状态的了解以及相关的行为改变，通过开始抗逆转录病毒治疗（ART）以及预防和治疗合并感染（如疟疾）来减少HIV在社区中的传播。以家庭为基础的艾滋病毒咨询和检测项目，即HBCT，已经实现了对艾滋病毒血清状况的大规模了解。我们将在HBCT平台（“HBCT +”）的基础上，为艾滋病毒感染者提供有针对性的诊断、预防和治疗服务，并提供行为咨询，以减少艾滋病毒的传染性，这将加强我们在乌干达的预防方法项目（MP-3）研究。我们将在乌干达一个艾滋病毒高发地区的5000户家庭中实施HIV -plus疗法，并在护理点进行CD4检测，按照乌干达的指导方针以及对所有艾滋病毒阳性者的合并感染进行预防和治疗，对艾滋病毒阳性者进行抗逆转录病毒治疗。我们将提供预防为积极的风险降低咨询和不和谐夫妻咨询，以减少风险行为。我们将进行为期一年的季度随访，以优化临床干预措施的采用，并评估风险行为和耻辱感。衡量hbv +治疗成功与否的标准是：1)社区病毒载量（社区12个月的平均HIV血浆病毒载量），这是人群水平HIV感染的标志；2)HIV传播潜力，这是HIV+患者与HIV或未知血清状态的伴侣之间的病毒载量和性行为的综合衡量指标，对HIV传播影响最大。具体目标：1)证明HIV -plus的可行性，包括艾滋病毒检测、POC CD4检测，以筛选艾滋病毒感染者进行护理，以及预防阳性和不一致的夫妇咨询，在一年内向乌干达5000个家庭提供服务，基础是艾滋病毒感染者中90%的检测使用率和80%的护理联系。2)通过评估HBCT-plus前后的社区病毒载量和HIV传播潜力，衡量HBCT-plus对社区HIV传播风险的影响。3)对新发现的HIV+患者进行HIV+ +阳性预防咨询前后的性行为频次、性伴侣及其家人的信息披露情况、性伴侣的HIV检测情况、安全套使用情况、性行为频次、性伴侣数量等进行评估。4)通过社区概率抽样调查，评估HBCT-plus对社区风险行为、HIV检测态度和污名化的影响。5)确定HBCT的增量成本和HBCT +中用于促进艾滋病毒护理和咨询的附加组件，并估计社区病毒载量降低的成本效益。